XFRA CAPITAL ADJUSTMENT INFORMATION

Realtime	Geld	Brief	Zeit
	0,003	0,017	21.12.
	0,007	0,008	20.12.

Realtime

Geld

Brief

Zeit

0,003

0,017

21.12.

0,007

0,008

20.12.

XFRA CAPITAL ADJUSTMENT INFORMATION - 11.03.2024

Das Instrument 2LU SE0010546242 ACCONEER AB EQUITY wird ex Kapitalmassnahme gehandelt am 11.03.2024
The instrument 2LU SE0010546242 ACCONEER AB EQUITY is traded ex capital adjustment on 11.03.2024

Das Instrument JUV IT0005572778 JUVENTUS FOOTBALL EQUITY wird ex Kapitalmassnahme gehandelt am 11.03.2024
The instrument JUV IT0005572778 JUVENTUS FOOTBALL EQUITY is traded ex capital adjustment on 11.03.2024

Das Instrument E7T AU000000AJX6 ALEXIUM INTERNATIONAL GRP EQUITY wird cum Kapitalmassnahme gehandelt am 11.03.2024 und ex Kapitalmassnahme am 12.03.2024
The instrument E7T AU000000AJX6 ALEXIUM INTERNATIONAL GRP EQUITY is traded cum capital adjustment on 11.03.2024 and ex capital adjustment on 12.03.2024

Das Instrument 5HTA US41358P2056 HARPOON THERAPEUTICS EQUITY wird cum Kapitalmassnahme gehandelt am 11.03.2024 und ex Kapitalmassnahme am 12.03.2024
The instrument 5HTA US41358P2056 HARPOON THERAPEUTICS EQUITY is traded cum capital adjustment on 11.03.2024 and ex capital adjustment on 12.03.2024

Das Instrument A28 NL0010872420 AFFIMED N.V. EO-,10 EQUITY wird ex Kapitalmassnahme gehandelt am 11.03.2024
The instrument A28 NL0010872420 AFFIMED N.V. EO-,10 EQUITY is traded ex capital adjustment on 11.03.2024

Das Instrument O0K CA07309M1041 BAYRIDGE RES CORP. EQUITY wird ex Kapitalmassnahme gehandelt am 11.03.2024
The instrument O0K CA07309M1041 BAYRIDGE RES CORP. EQUITY is traded ex capital adjustment on 11.03.2024

6 Richtige für 2025

Das Börsenjahr 2025 klopft schon an die Tür – und wie immer geht es um die Frage: Welche Aktien werden die großen Gewinner sein? Die Auswahl an Möglichkeiten ist riesig, doch nur ein paar echte Volltreffer stechen heraus.

Ob stabiler Dividenden-Lieferant, Tech-Pionier oder spekulative Wette im Krypto-Bereich – wir haben die Märkte für Sie ausgiebig durchforstet und präsentieren Ihnen 6 Unternehmen, die große Chancen auf außergewöhnliche Kurssteigerungen besitzen. Hier sind, speziell für Sie, Ihre „6 Richtigen“ für 2025.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche Unternehmen das Potenzial besitzen, im kommenden Jahr richtig durchzustarten!

Hier klicken

Zeit	Aktuelle Nachrichten
25.10.	Acconeer AB: Interim report Q3 2024		In the third quarter of 2024 Acconeer's net sales amounted to kSEK 14,604 and the gross margin was 61%. A record number of radar sensors were sold in the quarter, 400,000. A total of 10 new customer... ► Artikel lesen
19.07.	Acconeer AB: Interim report Q2 2024		In the second quarter 2024 Acconeer's net sales amounted to kSEK 15,138 and the gross margin was 61%. As many as nearly 270,000 radar sensors were sold in the quarter. In addition, more than 25,000... ► Artikel lesen

Zeit

Aktuelle Nachrichten

25.10.

Acconeer AB: Interim report Q3 2024

In the third quarter of 2024 Acconeer's net sales amounted to kSEK 14,604 and the gross margin was 61%. A record number of radar sensors were sold in the quarter, 400,000. A total of 10 new customer...
► Artikel lesen

19.07.

Acconeer AB: Interim report Q2 2024

In the second quarter 2024 Acconeer's net sales amounted to kSEK 15,138 and the gross margin was 61%. As many as nearly 270,000 radar sensors were sold in the quarter. In addition, more than 25,000...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Di	Affimed stock plunges 23% on AFM24 study update
Di	Affimed N.V. - 6-K, Report of foreign issuer
09.12.	Affimed N.V.: Affimed Reports Promising Phase 1 Efficacy and Safety Data for AFM28 in Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)	AFM28, a bispecific, tetravalent innate cell engager (ICE®) targeting CD123 and CD16A, achieved a 40% composite complete remission rate (CRcR) at the highest dose level (300 mg) in heavily pretreated... ► Artikel lesen
09.12.	Affimed reports data from mid-stage study of its lymphoma treatment
08.12.	Affimed N.V.: Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients	The combination of acimtamig with AlloNK® demonstrated an overall response rate of 86% and complete response of 55% in 22 heavily pretreated patients with R/R cHL, who have exhausted all standard... ► Artikel lesen

Zeit

Aktuelle Nachrichten

Affimed stock plunges 23% on AFM24 study update

Affimed N.V. - 6-K, Report of foreign issuer

09.12.

Affimed N.V.: Affimed Reports Promising Phase 1 Efficacy and Safety Data for AFM28 in Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

AFM28, a bispecific, tetravalent innate cell engager (ICE®) targeting CD123 and CD16A, achieved a 40% composite complete remission rate (CRcR) at the highest dose level (300 mg) in heavily pretreated...
► Artikel lesen

09.12.

Affimed reports data from mid-stage study of its lymphoma treatment

08.12.

Affimed N.V.: Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients

The combination of acimtamig with AlloNK® demonstrated an overall response rate of 86% and complete response of 55% in 22 heavily pretreated patients with R/R cHL, who have exhausted all standard...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Fr	ALEXIUM INTERNATIONAL GROUP LIMITED: Change of Director's Interest Notice - BB
Fr	ALEXIUM INTERNATIONAL GROUP LIMITED: Change of Director's Interest Notice - RB
Fr	ALEXIUM INTERNATIONAL GROUP LIMITED: Confirmation of Capital Structure
Fr	ALEXIUM INTERNATIONAL GROUP LIMITED: Notification regarding unquoted securities - AJX
Fr	ALEXIUM INTERNATIONAL GROUP LIMITED: Notification regarding unquoted securities - AJX

Zeit

Aktuelle Nachrichten

ALEXIUM INTERNATIONAL GROUP LIMITED: Change of Director's Interest Notice - BB

ALEXIUM INTERNATIONAL GROUP LIMITED: Change of Director's Interest Notice - RB

ALEXIUM INTERNATIONAL GROUP LIMITED: Confirmation of Capital Structure

ALEXIUM INTERNATIONAL GROUP LIMITED: Notification regarding unquoted securities - AJX

Zeit	Aktuelle Nachrichten
19.11.	Canalaska Uranium Ltd (2): Bayridge Resources talks drilling at Waterbury East
19.11.	Bayridge Resources Corp: Bayridge Resources talks drilling at Waterbury East
19.11.	Aktueller Stand der Bohrungen von Bayridge Resources im Projekt Waterbury East	Vancouver, British Columbia, 19. November 2024 / IRW-Press / Bayridge Resources Corp. (CSE: BYRG) (OTCQB: BYRFF) (FWB: O0k) ("Bayridge") hat das Bohrprogramm vom Herbst 2024 in seinem 1.337 ha... ► Artikel lesen
19.11.	Bayridge Resources Corp.: Bayridge Resources Drilling Update at Waterbury East Project	Vancouver, British Columbia--(Newsfile Corp. - November 19, 2024) - Bayridge Resources Corp. (CSE: BYRG) (OTCQB: BYRFF) (FSE: O0k) ("Bayridge") has completed the fall 2024 drilling program at its 1... ► Artikel lesen
16.10.	Canalaska Uranium Ltd (2): Bayridge drills first two holes at Waterbury East

Zeit

Aktuelle Nachrichten

19.11.

Canalaska Uranium Ltd (2): Bayridge Resources talks drilling at Waterbury East

19.11.

Bayridge Resources Corp: Bayridge Resources talks drilling at Waterbury East

19.11.

Aktueller Stand der Bohrungen von Bayridge Resources im Projekt Waterbury East

Vancouver, British Columbia, 19. November 2024 / IRW-Press / Bayridge Resources Corp. (CSE: BYRG) (OTCQB: BYRFF) (FWB: O0k) ("Bayridge") hat das Bohrprogramm vom Herbst 2024 in seinem 1.337 ha...
► Artikel lesen

19.11.

Bayridge Resources Corp.: Bayridge Resources Drilling Update at Waterbury East Project

Vancouver, British Columbia--(Newsfile Corp. - November 19, 2024) - Bayridge Resources Corp. (CSE: BYRG) (OTCQB: BYRFF) (FSE: O0k) ("Bayridge") has completed the fall 2024 drilling program at its 1...
► Artikel lesen

16.10.

Canalaska Uranium Ltd (2): Bayridge drills first two holes at Waterbury East

Zeit	Aktuelle Nachrichten
Fr	Milan: Juventus negative
Mi	UBS zu Man United und Juve: Eine Aktie ist ein Kauf, die andere sogar ein Verkauf
Di	UBS starts coverage of Manchester United stock at Buy, Juventus at Sell
Mo	Milan: Juventus trades in negative territory
13.12.	Milan: Juventus on the rise

Zeit

Aktuelle Nachrichten

Milan: Juventus negative

UBS zu Man United und Juve: Eine Aktie ist ein Kauf, die andere sogar ein Verkauf

UBS starts coverage of Manchester United stock at Buy, Juventus at Sell

Milan: Juventus trades in negative territory

13.12.

Milan: Juventus on the rise

Unternehmen / Aktien	Kurs	%
ACCONEER AB	0,356	+3,79 %
AFFIMED NV	1,140	+0,44 %
ALEXIUM INTERNATIONAL GROUP LIMITED	0,009	+20,00 %
BAYRIDGE RESOURCES CORP	0,058	+8,41 %
JUVENTUS FOOTBALL CLUB SPA	3,050	+0,66 %

Unternehmen / Aktien

Kurs

ACCONEER AB

0,356

+3,79 %

AFFIMED NV

1,140

+0,44 %

ALEXIUM INTERNATIONAL GROUP LIMITED

0,009

+20,00 %

BAYRIDGE RESOURCES CORP